Clinical Trial Update: AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lomitapide (AEGR-733) with atorvastatin 20 mg versus atorvastatin monotherapy in adults with hypercholesterolemia; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• JUXTAPID (lomitapide)
• Lipitor (atorvastatin)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-21